Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04264013

The Eggs and actiVity in hEalth agiNg Pilot (EVEN-P) Trial in Older Persons

Eggs as Nutrient-Rich Source of Protein to Enhance Activity-Related Health in Older Persons: The Eggs and actiVity in hEalth agiNg Pilot (EVEN-P) Trial

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
McMaster University · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

Two of the most effective lifestyle-based approaches to reduce the risk of adverse health events and enhance quality of life with aging are exercise and a healthy diet. Currently, the Canadian recommended dietary allowance (RDA) for protein is 0.8 g/kg/day, however, several expert groups have advocated for a higher RDA of protein (\~1.2 g/kg/day), along with more evenly distributed daily consumption, in older persons. Eggs are considered a nutrient-rich protein source but have recently been scrutinized. This study will compare a high-protein, egg-containing diet and a high-protein, non-egg diet in healthy older persons.

Detailed description

This study will examine the impacts of an egg-containing diet and a non-egg diet in healthy older persons. Briefly, participants (healthy persons, age 60-75 years old) will consume their normal diet or their normal diet plus 4 eggs completing a structured exercise program (designed to meet Canada's Physical Activity Guidelines) for a total of 12 weeks. Participants will be randomly assigned to the Egg or Control (non-egg) group. Before and after the 12-week intervention, participants' undergo assessments of diet-quality, muscle health, fitness, bone health, and vascular health.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExerciseParticipants will exercise in a supervised facility twice weekly and consume their habitual diet.
BEHAVIORALExercise plus diet (egg)Participants will exercise in a supervised facility twice weekly and consume an addiitonal 4 eggs per day.

Timeline

Start date
2020-05-01
Primary completion
2021-03-01
Completion
2021-05-01
First posted
2020-02-11
Last updated
2023-03-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04264013. Inclusion in this directory is not an endorsement.